Artisan Partners reports 4.2% stake in Ascendis Pharma
Artisan Partners Asset Management Inc., together with affiliated entities, reports beneficial ownership of Ascendis Pharma A/S ordinary shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Artisan Partners Asset Management Inc., together with affiliated entities, reports beneficial ownership of Ascendis Pharma A/S ordinary shares. The group beneficially owns 2,634,024 ordinary shares, representing 4.2% of the class, based on 61,977,408 shares outstanding as of May 11, 2026.
The group has shared voting power over 2,422,862 shares and shared dispositive power over all 2,634,024 shares, with no sole voting or dispositive power. The filing states ownership of 5 percent or less of the class and identifies Artisan Partners Limited Partnership as an investment adviser registered under the Investment Advisers Act of 1940.
Key Figures
Key Terms
beneficially owned financial
Investment Advisers Act of 1940 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which entities are included in Artisan Partners’ Ascendis Pharma (ASND) ownership filing?
What is the role of Artisan Partners Limited Partnership in the Ascendis Pharma (ASND) stake?
AI-generated analysis. How Rhea-AI works. Not financial advice.